免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Dexcom G6 葡萄糖程序连续葡萄糖监测(CGM)系统

K号: K203089 · 2021-08-17

申请人Dexcom, Inc.
决定日期2021-08-17
产品代码QDK
咨询委员会CH 请注意,您提供的文本“CH”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System is the device name listed in this FDA 510(k) record. The listed applicant is Dexcom, Inc.. It received FDA 510(k) clearance on 2021-08-17 under 510(k) number K203089. The device is classified under product code QDK. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System?

Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System is a medical device that received FDA 510(k) clearance on 2021-08-17. The listed applicant is Dexcom, Inc.. The 510(k) number is K203089.

When did Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System receive FDA 510(k) clearance?

Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System received FDA 510(k) clearance on 2021-08-17, under 510(k) number K203089.

Who is the listed applicant for Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System?

FDA 510(k)记录中列出Dexcom,Inc.为申请人。这本身并不足以确立该设备制造商的身份。

What is the FDA product code for Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System?

The FDA product code for Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System is QDK.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Dexcom, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 25 个设备 →

相关器械(代码:QDK)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑